171 related articles for article (PubMed ID: 17889483)
1. False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam--is it still an issue?
Penack O; Rempf P; Graf B; Thiel E; Blau IW
Diagn Microbiol Infect Dis; 2008 Jan; 60(1):117-20. PubMed ID: 17889483
[TBL] [Abstract][Full Text] [Related]
2. False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?
Orlopp K; von Lilienfeld-Toal M; Marklein G; Reiffert SM; Welter A; Hahn-Ast C; Purr I; Gorschlüter M; Molitor E; Glasmacher A
J Antimicrob Chemother; 2008 Nov; 62(5):1109-12. PubMed ID: 18647743
[TBL] [Abstract][Full Text] [Related]
3. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.
Sulahian A; Touratier S; Ribaud P
N Engl J Med; 2003 Dec; 349(24):2366-7. PubMed ID: 14668472
[No Abstract] [Full Text] [Related]
4. False positive galactomannan Platelia due to piperacillin-tazobactam.
Gerlinger MP; Rousselot P; Rigaudeau S; Billon C; Touratier S; Castaigne S; Eloy O
Med Mal Infect; 2012 Jan; 42(1):10-4. PubMed ID: 22153703
[TBL] [Abstract][Full Text] [Related]
5. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
6. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.
Walsh TJ; Shoham S; Petraitiene R; Sein T; Schaufele R; Kelaher A; Murray H; Mya-San C; Bacher J; Petraitis V
J Clin Microbiol; 2004 Oct; 42(10):4744-8. PubMed ID: 15472335
[TBL] [Abstract][Full Text] [Related]
7. Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
Vergidis P; Razonable RR; Wheat LJ; Estes L; Caliendo AM; Baden LR; Wingard JR; Baddley J; Assi M; Norris S; Chandrasekar P; Shields R; Nguyen H; Freifeld A; Kohler R; Kleiman M; Walsh TJ; Hage CA
J Clin Microbiol; 2014 Jun; 52(6):2199-201. PubMed ID: 24719434
[TBL] [Abstract][Full Text] [Related]
8. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.
Viscoli C; Machetti M; Cappellano P; Bucci B; Bruzzi P; Van Lint MT; Bacigalupo A
Clin Infect Dis; 2004 Mar; 38(6):913-6. PubMed ID: 14999640
[TBL] [Abstract][Full Text] [Related]
9. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma.
Mori Y; Nagasaki Y; Kamezaki K; Takenaka K; Iwasaki H; Harada N; Miyamoto T; Abe Y; Shimono N; Akashi K; Teshima T
Am J Hematol; 2010 Jun; 85(6):449-51. PubMed ID: 20513124
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of Aspergillus galactomannan levels in antimicrobial agents].
Yücesoy M; Ergon MC
Mikrobiyol Bul; 2007 Oct; 41(4):565-70. PubMed ID: 18173075
[TBL] [Abstract][Full Text] [Related]
11. Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia.
Demiraslan H; Atalay MA; Eren E; Demir K; Kaynar L; Koc AN; Doganay M
Med Mycol; 2017 Jul; 55(5):535-540. PubMed ID: 27915301
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay.
Mikulska M; Furfaro E; Del Bono V; Raiola AM; Ratto S; Bacigalupo A; Viscoli C
J Antimicrob Chemother; 2012 Jul; 67(7):1746-8. PubMed ID: 22499998
[TBL] [Abstract][Full Text] [Related]
13. False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.
Fortún J; Martín-Dávila P; Alvarez ME; Norman F; Sánchez-Sousa A; Gajate L; Bárcena R; Nuño SJ; Moreno S
Transplantation; 2009 Jan; 87(2):256-60. PubMed ID: 19155981
[TBL] [Abstract][Full Text] [Related]
14. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments.
Bart-Delabesse E; Basile M; Al Jijakli A; Souville D; Gay F; Philippe B; Bossi P; Danis M; Vernant JP; Datry A
J Clin Microbiol; 2005 Oct; 43(10):5214-20. PubMed ID: 16207986
[TBL] [Abstract][Full Text] [Related]
15. Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market.
Xavier MO; Pasqualotto AC; Aquino VR; Sukiennik TC; Severo LC
Braz J Infect Dis; 2009 Oct; 13(5):353-5. PubMed ID: 20428634
[TBL] [Abstract][Full Text] [Related]
16. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.
Adam O; Aupérin A; Wilquin F; Bourhis JH; Gachot B; Chachaty E
Clin Infect Dis; 2004 Mar; 38(6):917-20. PubMed ID: 14999641
[TBL] [Abstract][Full Text] [Related]
17. False-positive Aspergillus galactomannan antigen test results.
Maertens J; Theunissen K; Verhoef G; Van Eldere J
Clin Infect Dis; 2004 Jul; 39(2):289-90. PubMed ID: 15307045
[No Abstract] [Full Text] [Related]
18. False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam.
Alhambra A; Cuétara MS; Ortiz MC; Moreno JM; del Palacio A; Pontón J; del Palacio A
Rev Iberoam Micol; 2007 Jun; 24(2):106-12. PubMed ID: 17604427
[TBL] [Abstract][Full Text] [Related]
19. False-positive Aspergillus galactomannan (GM) assay in histoplasmosis.
Narreddy S; Chandrasekar PH
J Infect; 2008 Jan; 56(1):80-1. PubMed ID: 17983658
[No Abstract] [Full Text] [Related]
20. Lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen.
Oren I; Avidor I; Sprecher H
Transpl Infect Dis; 2012 Feb; 14(1):107-9. PubMed ID: 21733049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
